ArticleBMC neurology2026
Association of antibodies against neural antigens with futile reperfusion in patients with anterior circulation large vessel occlusion ischemic stroke after endovascular treatment: a cohort study.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe prevalence and titer patterns of anti-neuronal antibodies in patients with large vessel occlusion (LVO) strokes remain unclear. The relationship between anti-neuronal antibodies and ischemic stroke prognosis remains debated. This cohort study aimed to clarify the prevalence and titer characteristics of anti-neuronal antibodies in patients with anterior circulation LVO stroke and to examine their effect on outcomes following endovascular treatment.
methodWe retrospectively analyzed data from consecutive patients with first-ever acute ischemic stroke due to anterior circulation LVO admitted to Xi'an No. 3 Hospital (China) between November 2019 and September 2023. Logistic regression and propensity score matching were utilized to explore the relationship between anti-neuronal antibodies and outcomes in anterior circulation LVO stroke patients. Sensitivity analysis was conducted by calculating E-values and adjusting the caliper width for propensity score matching.
resultsAmong 153 patients, 28 tested positive for antibodies against neuronal antigens, with anti-N-methyl-D-aspartate receptor 1 (NMDAR1)-IgM being the most common. Anti-dipeptidyl-peptidase (DPPX)-IgG showed the highest titers, while anti-NMDAR1-IgM was predominantly low-titer. The presence of anti-neuronal antibodies is significantly and negatively correlated with a favorable prognosis following endovascular treatment in stroke patients with anterior circulation LVO. (ORs: 0.12-0.28, all p < 0.05). E-values ranged from 3.19 to 5.22, and adjusting the caliper to 0.1 confirmed the robustness of the study's findings.
conclusionsAnti-neuronal antibodies may be associated with an increased risk of futile recanalization in patients with anterior-circulation large-vessel occlusion stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.